These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8219496)
21. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Park YK; Jung SI; Park KH; Kim SH; Ko KS Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405 [TBL] [Abstract][Full Text] [Related]
22. Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter haemolyticus strain ATCC 17906. Haseley SR; Holst O; Brade H Eur J Biochem; 1997 Mar; 244(3):761-6. PubMed ID: 9108245 [TBL] [Abstract][Full Text] [Related]
23. Structural studies of the O-antigen isolated from the phenol-soluble lipopolysaccharide of Acinetobacter baumannii (DNA group 2) strain 9. Haseley SR; Holst O; Brade H Eur J Biochem; 1998 Jan; 251(1-2):189-94. PubMed ID: 9492283 [TBL] [Abstract][Full Text] [Related]
24. Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients. Lee HY; Chen CL; Wu SR; Huang CW; Chiu CH Crit Care Med; 2014 May; 42(5):1081-8. PubMed ID: 24394630 [TBL] [Abstract][Full Text] [Related]
25. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. Kim SW; Choi CH; Moon DC; Jin JS; Lee JH; Shin JH; Kim JM; Lee YC; Seol SY; Cho DT; Lee JC FEMS Microbiol Lett; 2009 Dec; 301(2):224-31. PubMed ID: 19878322 [TBL] [Abstract][Full Text] [Related]
26. Molecular typing of Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolates from endemic and epidemic nosocomial infections. Ratto P; Sordelli DO; Abeleira E; Torrero M; Catalano M Epidemiol Infect; 1995 Feb; 114(1):123-32. PubMed ID: 7867730 [TBL] [Abstract][Full Text] [Related]
27. O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies. Pantophlet R; Nemec A; Brade L; Brade H; Dijkshoorn L J Clin Microbiol; 2001 Jul; 39(7):2576-80. PubMed ID: 11427571 [TBL] [Abstract][Full Text] [Related]
28. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea. Park YK; Lee GH; Baek JY; Chung DR; Peck KR; Song JH; Ko KS Microb Drug Resist; 2010 Jun; 16(2):143-9. PubMed ID: 20370437 [TBL] [Abstract][Full Text] [Related]
29. Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia. Bruhn KW; Pantapalangkoor P; Nielsen T; Tan B; Junus J; Hujer KM; Wright MS; Bonomo RA; Adams MD; Chen W; Spellberg B J Infect Dis; 2015 Apr; 211(8):1296-305. PubMed ID: 25378635 [TBL] [Abstract][Full Text] [Related]
30. Identification of immunogenic proteins of the bacterium Acinetobacter baumannii using a proteomic approach. Fajardo Bonin R; Chapeaurouge A; Perales J; da Silva JG; do Nascimento HJ; D'Alincourt Carvalho Assef AP; Moreno Senna JP Proteomics Clin Appl; 2014 Dec; 8(11-12):916-23. PubMed ID: 24899143 [TBL] [Abstract][Full Text] [Related]
31. Acinetobacter pittii isolated more frequently than Acinetobacter baumannii in blood cultures: the experience of a French hospital. Pailhoriès H; Tiry C; Eveillard M; Kempf M J Hosp Infect; 2018 Jul; 99(3):360-363. PubMed ID: 29577994 [TBL] [Abstract][Full Text] [Related]
32. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. McConnell MJ; Rumbo C; Bou G; Pachón J Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737 [TBL] [Abstract][Full Text] [Related]
33. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Seifert H; Strate A; Pulverer G Medicine (Baltimore); 1995 Nov; 74(6):340-9. PubMed ID: 7500897 [TBL] [Abstract][Full Text] [Related]
34. Phenotypic and genotypic characterization of clinically recovered presumptive Acinetobacter baumannii isolates which failed to grow at 44 degrees C. Traub WH; Bauer D; Leonhard B Zentralbl Bakteriol; 1996 Sep; 285(1):29-34. PubMed ID: 8946693 [TBL] [Abstract][Full Text] [Related]
35. Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter junii strain 65. Haseley SR; Pantophlet R; Brade L; Holst O; Brade H Eur J Biochem; 1997 Apr; 245(2):477-81. PubMed ID: 9151982 [TBL] [Abstract][Full Text] [Related]
36. Bacteremia due to Acinetobacter species other than Acinetobacter baumannii. Seifert H; Strate A; Schulze A; Pulverer G Infection; 1994; 22(6):379-85. PubMed ID: 7698833 [TBL] [Abstract][Full Text] [Related]
37. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Fattahian Y; Rasooli I; Mousavi Gargari SL; Rahbar MR; Darvish Alipour Astaneh S; Amani J Microb Pathog; 2011 Dec; 51(6):402-6. PubMed ID: 21946278 [TBL] [Abstract][Full Text] [Related]
38. Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B. Plested JS; Gidney MA; Coull PA; Griffiths HG; Herbert MA; Bird AG; Richards JC; Moxon ER J Immunol Methods; 2000 Apr; 237(1-2):73-84. PubMed ID: 10725453 [TBL] [Abstract][Full Text] [Related]
39. A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii: Characterization of the strain and antibiotic susceptibility studies. Traub WH; Geipel U; Schwarze I; Bauer D Chemotherapy; 1999; 45(5):349-59. PubMed ID: 10473923 [TBL] [Abstract][Full Text] [Related]
40. Nosocomial bacteremia due to an as yet unclassified acinetobacter genomic species 17-like strain. Rodriguez-Baño J; Martí S; Ribera A; Fernández-Cuenca F; Dijkshoorn L; Nemec A; Pujol M; Vila J J Clin Microbiol; 2006 Apr; 44(4):1587-9. PubMed ID: 16597902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]